Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tetratherix Limited ( (AU:TTX) ) just unveiled an announcement.
Tetratherix Limited has announced the release of its FY25 Results and Annual Report, along with the release of restricted securities from ASX mandatory and voluntary escrow. The release of these shares, totaling over 542,000 fully paid ordinary shares, marks a significant step in the company’s financial operations and could impact its market positioning and stakeholder interests.
The most recent analyst rating on (AU:TTX) stock is a Buy with a A$5.72 price target. To see the full list of analyst forecasts on Tetratherix Limited stock, see the AU:TTX Stock Forecast page.
More about Tetratherix Limited
Tetratherix Limited is a company that develops novel clinical products utilizing its patented biomaterial polymer platform technology.
Average Trading Volume: 56,608
See more insights into TTX stock on TipRanks’ Stock Analysis page.